Biomerics LLC, a medical device contract manufacturer headquartered in Salt Lake City, has acquired FutureMatrix Interventional Inc. (FMI) of Athens, Texas. FMI specializes in the design and manufacture of interventional catheters for the cardiovascular and urinary markets.
“We are pleased to add FMI’s capabilities to the Biomerics portfolio,” said Biomerics CEO Travis Sessions. “We welcome the FMI team to the group and look forward to their contribution. This acquisition expands our capabilities and important customer relationships. We look forward to investing in and expanding the business for our customers, employees and community. Combining FMI with Biomerics’ existing medical device business establishes Biomerics as a leader in the attractive minimally invasive interventional segment of the medical device market.”
FMI, founded in 1993 by James Passmore, started by developing balloon catheters. Over the years, the company expanded its technologies and developed other peripheral cardiovascular, kidney stone management and urinary catheters. Today, it operates a 50,000-square-foot manufacturing space and employs more than 400 employees.
Biomerics, with over 1000 employees, operates seven facilities located in Utah, Minnesota, Indiana, Costa Rica and Texas. Founded in 2009, Biomerics has grown into a market leader in the minimally invasive interventional catheter market. Biomerics provides engineered components to the medical device market including biomaterials, extrusions, molded parts, laser processed parts, machined parts, balloons, and reinforced shafts. I also supplies packaged sterile medical devices including advanced interventional catheters, surgical tools, and vascular access products.